Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.67B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.58B |
| 3 |
TE Connectivity
TEL
|
+$948M |
| 4 |
Tesla
TSLA
|
+$910M |
| 5 |
Boeing
BA
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$1.7B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Visa
V
|
+$1.5B |
| 4 |
Morgan Stanley
MS
|
+$1.27B |
| 5 |
Exelon
EXC
|
+$1.19B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.17% |
| 2 | Healthcare | 17.88% |
| 3 | Financials | 14.68% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Chemed
CHE
$7.05B
| $1.19M | ﹤0.01% |
2,244
-998
| -31% | -$563K |
|
1602
Western Union
WU
$2.28B
| $1.19M | ﹤0.01% |
111,978
+46,021
| +70% | +$510K |
|
1603
Zimmer Biomet
ZBH
$18.5B
| $1.18M | ﹤0.01% |
11,152
-25,916
| -70% | -$2.78M |
|
1604
Erasca
ERAS
$6.38B
| $1.17M | ﹤0.01% |
+465,672
| New | +$1.28M |
|
1605
Super Micro Computer
SMCI
$20.5B
| $1.13M | ﹤0.01% |
37,133
-28,947
| -44% | -$1.05M |
|
1606
Aflac
AFL
$63.7B
| $1.13M | ﹤0.01% |
10,932
-50,701
| -82% | -$5.53M |
|
1607
OP Bancorp
OPBK
$235M
| $1.13M | ﹤0.01% |
71,486
| – | – |
|
1608
Expro Ltd
XPRO
$1.88B
| $1.13M | ﹤0.01% |
90,436
-359,090
| -80% | -$5M |
|
1609
Mineralys Therapeutics
MLYS
$2.34B
| $1.13M | ﹤0.01% |
91,529
+27,531
| +43% | +$360K |
|
|
SWTX
1610
DELISTED
SpringWorks Therapeutics
SWTX
| $1.13M | ﹤0.01% |
31,181
-3,813
| -11% | -$133K |
|
1611
ArriVent BioPharma
AVBP
$1.47B
| $1.12M | ﹤0.01% |
+41,921
| New | +$1.2M |
|
1612
PUT
Texas Pacific Land
TPL
$27.3B
| $1.11M | ﹤0.01% |
+321
| New | +$131K |
|
1613
Phathom Pharmaceuticals
PHAT
$684M
| $1.1M | ﹤0.01% |
135,995
-37,388
| -22% | -$463K |
|
1614
Restaurant Brands International
QSR
$25.6B
| $1.1M | ﹤0.01% |
16,935
-1,030
| -6% | -$71.5K |
|
1615
Aura Biosciences
AURA
$740M
| $1.08M | ﹤0.01% |
131,054
+14,662
| +13% | +$138K |
|
|
CPRX
1616
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.08M | ﹤0.01% |
51,550
-8,034
| -13% | -$173K |
|
1617
Howmet Aerospace
HWM
$115B
| $1.07M | ﹤0.01% |
9,816
+6,900
| +237% | +$756K |
|
1618
Flowers Foods
FLO
$1.55B
| $1.07M | ﹤0.01% |
+51,651
| New | +$1.14M |
|
1619
MacroGenics
MGNX
$248M
| $1.05M | ﹤0.01% |
323,857
+16,717
| +5% | +$60.2K |
|
1620
Broadridge
BR
$19.5B
| $1.05M | ﹤0.01% |
4,636
+1,026
| +28% | +$230K |
|
|
YMAB
1621
DELISTED
Y-mAbs Therapeutics
YMAB
| $1.04M | ﹤0.01% |
133,263
-3,451
| -3% | -$42K |
|
1622
Arrowhead Research
ARWR
$12.6B
| $1.04M | ﹤0.01% |
55,396
-6,508
| -11% | -$134K |
|
|
KALV
1623
DELISTED
KalVista Pharmaceuticals
KALV
| $1.04M | ﹤0.01% |
122,863
+4,940
| +4% | +$51.2K |
|
1624
State Street Utilities Select Sector SPDR ETF
XLU
$22.8B
| $1.03M | ﹤0.01% |
27,312
-7,444
| -21% | -$295K |
|
1625
Strategy Inc
MSTR
$35.7B
| $1.03M | ﹤0.01% |
3,565
-3,162
| -47% | -$951K |
|
Similar funds
Wellington Management Group's Q4 2024 Portfolio in Review
As of Q4 2024, Wellington Management Group held 2,066 positions worth $546B, down 4.3% from $571B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wellington Management Group withdrew a net $25.7B in Q4 2024, closing 139 positions and reducing 894 holdings. Its most notable exit was Lineage Inc, an estimated $266M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Wellington Management Group opened a new position in TE Connectivity worth $910M.
- Wellington Management Group's largest Q4 2024 buy was TE Connectivity: 6,362,160 shares worth $910M.
- Wellington Management Group added most to Eli Lilly in Q4 2024, an estimated $1.67B increase.
- Wellington Management Group's biggest Q4 2024 reduction was General Dynamics, cutting an estimated $1.7B.
- Wellington Management Group fully exited Lineage Inc in Q4 2024, selling an estimated $266M.
- Wellington Management Group's ten largest holdings make up 25% of its $546B portfolio in Q4 2024.
- Wellington Management Group opened 161 new positions and closed 139 in Q4 2024.
- Wellington Management Group's portfolio value fell 4.3% quarter-over-quarter to $546B.
Based on Wellington Management Group's 13F filing for Q4 2024, filed 12 Feb 2025.